Superdonor FMT in Patients With Ulcerative Colitis
Evaluation of the Efficacy of Superdonor Fecal Microbiota Transplantation in Patients With Mild-to-moderate Ulcerative Colitis: a Double-blind Randomized Controlled Trial
Sponsor: Fondazione Policlinico Universitario Agostino Gemelli IRCCS
This PHASE1/PHASE2 trial investigates Active Ulcerative Colitis and is currently actively recruiting participants. Fondazione Policlinico Universitario Agostino Gemelli IRCCS leads this study, which shows 5 recorded versions since 2023 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.
Status Flow
Change History
5 versions recorded-
Sep 2025 — Present [monthly]
Recruiting PHASE1/PHASE2
-
Apr 2025 — Sep 2025 [monthly]
Recruiting PHASE1/PHASE2
-
Sep 2024 — Apr 2025 [monthly]
Recruiting PHASE1/PHASE2
-
Jul 2024 — Sep 2024 [monthly]
Recruiting PHASE1/PHASE2
Phase: PHASE1_PHASE2 → PHASE1/PHASE2
-
Mar 2023 — Jul 2024 [monthly]
Recruiting PHASE1_PHASE2
First recorded
Feb 2023
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Fondazione Policlinico Universitario Agostino Gemelli IRCCS
For direct contact, visit the study record on ClinicalTrials.gov .